February 01, 2015 2:46 AM ET


Company Overview of Akesis Pharmaceuticals, Inc.

Company Overview

Akesis Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of Type 2 diabetes. Its products include AKP-020, a vanadium-based monotherapy that is in Phase IIa clinical trial for the treatment for Type 2 diabetes. Akesis Pharmaceuticals has a license agreement with the University of British Columbia (UBC) to use, commercialize, and sublicense technology owned by UBC relating to the treatment of diabetes and other related disorders. The company was founded in 1990 and is based in La Jolla, California. On January 30, 2009, Akesis Pharmaceuticals Inc filed a voluntary petition for liquidation under ...

888 Prospect Street

Suite 320

La Jolla, CA 92037

United States

Founded in 1990

2 Employees





Key Executives for Akesis Pharmaceuticals, Inc.

Akesis Pharmaceuticals, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
InvaGen Pharmaceuticals, Inc. United States
Sulfagenix Inc. United States
Symphony Allegro, Inc. United States
Pharmetrics Specialty Rx, LLC United States
Sustainable Community Development, L.L.C. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Akesis Pharmaceuticals, Inc., please visit www.akesis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.